MedImmune‘s FluMist, the only needle-free flu vaccine available in the U.S., has regained the support of an expert panel at the Centers for Disease Control & Prevention.
The Advisory Committee on Immunization Practices has voted to recommend the nasal spray’s use, reversing a two-year-old decision to keep the product out of clinics due to efficacy concerns.
Get the full story at our sister site, Drug Delivery Business News.
The post Needle-free flu vaccine will be back in clinics next flu season appeared first on MassDevice.